RankingsPricing
  1. US-listed companies
  2. Amphastar Pharmaceuticals, Inc.
  3. Raw

Amphastar Pharmaceuticals, Inc.AMPH

Market cap
$1.2B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Net income-----74716391138160
Loss on disposal of assets------1-0-0-0-0-0
Impairment of long-lived assets---------3-
Loss (gain) on interest rate swaps and foreign currency transactions, net--------2-53
Depreciation1311121315172022242528
Amortization of intangible assets2233211111325
Operating lease right-of-use asset amortization-------3444
Amortization of Debt Issuance Costs---------116
Equity in losses of unconsolidated affiliate--------0-1-2-1
Share-based compensation expense812151717172019182024
Changes in reserve for uncertain tax positions-0-000-03121-11
Changes in deferred taxes, net9-84-41-50-2161318
Accounts receivable, net-111-6816-72015102622
Inventories-7-1010-19641-15-112249
Prepaid expenses and other assets01-15-142-42311
Income tax refunds, deposits, and payable, net---12-4-11-853-7
Operating lease liabilities------3-4-3-3-4-4
Accounts payable and accrued liabilities6-3-1729-12213-11364
Net cash provided by operating activities---393842579889184213
BAQSIMI acquisition---------506129
Purchases and construction of property, plant, and equipment1914213547423427243841
Proceeds from Sale of Property, Plant, and Equipment-0--0---0--
Purchase of investments--460914173614577
Maturity of investments--340-12192839126
Deposits and other assets-151-00131-14
Net cash used in investing activities----39-42-51-36-29-33-649-125
Proceeds from equity plans, net of withholding tax payments-1421149323161611-
Proceeds from equity plans, net of withholding tax payments----------5
Purchase of treasury stock010103125222429405885
Debt issuance costs-------20251
Proceeds from Lines of Credit25---0-1---18
Repayments under lines of credit40----0-1---
Proceeds from Issuance of long-term debt277101984670-845-
Principal payments on long-term debt8915106683723198
Net cash provided by (used in) financing activities----825-4-2-37-26454-81
Effect of exchange rate changes on cash------00-0-0-0-0
Net increase (decrease) in cash, cash equivalents, and restricted cash------13193230-127
Deferred Payment For Acquisition---------122-
Capital Expenditures Incurred but Not yet Paid-----11119546
Noncash Operating Lease Right Of Use Asset-----851121119
Lease Obligation Incurred001-00001--
Interest paid, net of capitalized interest---2222231827
Income taxes paid00350638444940